News | February 02, 2015

SCAI 2015 Hildner Lecture Will Highlight Critical Need for More Clinical Research in Interventional Cardiology

Robert Harrington, M.D. of Stanford to deliver lecture at SCAI 2015 scientific sessions

Cath lab

Image courtesy of GE Healthcare

February 2, 2015 — New clinical research is essential to the development of hospital quality measurement, public reporting and pay-for-performance programs, according to Robert Harrington, M.D., FSCAI, chair of the Department of Medicine at Stanford University School of Medicine, who will present the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions Hildner Lecture, “The Future of Clinical Research in Interventional Cardiology: Challenges and Opportunities,” on Friday, May 8, in San Diego. In his lecture, Harrington will argue that simplification of larger trials, better early-phase investigations and the use of electronic health records can ease the path to new research.

“There needs to be a commitment on behalf of interventional cardiology to make sure that we get those quality indicators right,” said Harrington, “and the way we do that is through clinical investigation.”

Harrington is an internationally recognized expert in clinical research, having led the world’s largest academic clinical research organization, Duke Clinical Research Institute. During his five years in this role, his more than 200 faculty and 1,200 staff members conducted studies in 65 countries. After nearly two decades at Duke, he joined the Stanford Department of Medicine in 2012, where he currently heads 330 faculty in 14 divisions.

In his SCAI 2015 lecture, Harrington will discuss why the demand for research is especially high now, as emphasis continues to build for following practice guidelines and appropriate use criteria and for meeting new quality improvement benchmarks. Evidence-based guidelines established by professional societies are the foundation for clinical practice, and there is an expectation by the public that physicians are following these guidelines, said Harrington.

“Clinical research,” Harrington stressed, “is what makes these guidelines possible. Increasingly, reimbursement is tied to some of these performance and quality performance indicators.”

He will also discuss the challenges of integrating clinical research into practice because of the complexity of the rules and regulations that govern research. Further complicating clinical research is the challenge of limited funding, particularly from the National Institutes of Health, according to Harrington. Partnerships with industry and increased lobbying have become important for generating research dollars, but these efforts are complicated.

“The intense examination of relationships between clinical academic researchers and industry partners has threatened the ability to do excellent collaborative work,” he said.

Harrington hopes to inspire the invasive and interventional cardiologists attending SCAI 2015 to undertake more clinical research and stimulate interest in their younger peers, who will require a considerable amount of training before they are ready to venture out into the research environment on their own.

“We face a difficult road, and we have to pay attention to the next generation of clinical investigators,” he said. “The need for evidence is not going to diminish, and we need people who can generate it, interpret it and disseminate it.”

For more information: www.SCAI.org/SCAI2015

 

 

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init